Actions Panel
HEPATIC (HCC workshop) - New York City
Join a panel of expert faculty in this interactive half-day workshop discussing the HCC treatments and the multidisciplinary team.
When and where
Date and time
Monday, May 1 · 9am - 1:30pm EDT
Location
Executive Conference Center 1601 Broadway New York, NY 10010
About this event
- 4 hours 30 minutes
- Mobile eTicket
Earn 4.5 hours of educational credit at a complimentary summit on HCC treatments
Overview
The goal of this initiative is to provide the latest clinical information to increase clinicians’ knowledge and improve their competence confidence in providing the most accurate recommendations for treatment as members of the multidisciplinary HCC cancer treatment team.
Participants will actively engage in interactive small-group activities, including:
- A multidisciplinary HCC tumor board panel
- Breakout sessions delving into tissue sample issues, and treatment options for early, intermediate and advanced HCC
- Patient counseling and shared decision-making
Expert Faculty
- Adam Burgoyne, MD, PhD – University of California, San Diego
- Rony Avritscher, MD, FSIR - MD Anderson Cancer Center
- Jingmei Lin, MD, PhD - Indiana University Health
- Stacey Stein, MD - Yale Medicine
- Deborah Christensen, MSN, APRN, AOCNS, OCN - Cancer Commons
- Elizabeth Verna, MD - Columbia University
- Kirema Garcia-Reyes, MD - Mount Sinai
- Sarah Manes, MS, CCLS - Global Liver Institute
Agenda
- 8:50am: Doors open
- 9:00am: Workshop begins with Tumor Board (light breakfast provided)
- 10:00am: Breakout sessions: (1)HCC Diagnostic, Tissue Acquisition and Interpretation Challenges; (2) Treatment for Early and Intermediate HCC; (3) Treatment for Advanced HCC; (4) Patient Perspectives
- 12:00pm: Problem-Based Learning exercise- HCC patient cases
- 1:00pm: Action planning and Summary Report Outs
- 1:30pm: Workshop concludes (boxed lunch grab-n-go provided)
Visit The France Foundation Registration page for additional information
This activity is provided by an educational grant from AstraZeneca.